Cholesteryl ester transfer protein inhibition for coronary heart disease prevention: Real hope or despair?

被引：8
|
作者：
Frishman, William H. [1 ]
Barkowski, Rakhi Shah [2 ]
机构：
[1] New York Med Coll, Westchester Cty Med Ctr, Dept Med, Valhalla, NY 10595 USA
[2] Univ Calif Los Angeles, Med Ctr, David Geffen Sch Med, Dept Med, Los Angeles, CA 90024 USA
来源：
AMERICAN JOURNAL OF MEDICINE | 2008年 / 121卷 / 08期
关键词：
D O I：
10.1016/j.amjmed.2008.02.040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：644 / 646
页数：3
相关论文
共 50 条
  • [21] Inhibitors of cholesteryl ester transfer protein - a new approach to coronary artery disease
    Doggrell, SA
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (02) : 99 - 106
  • [22] WCC 22-Cholesteryl ester transfer protein inhibitors: A potential new therapy for coronary heart disease
    Hunt, Julianne A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [23] Cholesteryl ester transfer protein inhibition, high-density lipoprotein metabolism and heart disease risk reduction
    Schaefer, Ernst J.
    Asztalos, Bela F.
    CURRENT OPINION IN LIPIDOLOGY, 2006, 17 (04) : 394 - 398
  • [24] Cholesteryl Ester Transfer Protein Penetrates Lipoproteins For Cholesteryl Ester Transfer
    Ren, Gang
    Zhang, Shengli
    Cavigiolio, Giorgio
    Lei, Dongsheng
    Oda, Michael
    Weisgraber, Karl H.
    Rye, Kerry-Anne
    Pownall, Henry J.
    Qiu, Xiayang
    BIOPHYSICAL JOURNAL, 2010, 98 (03) : 36A - 36A
  • [25] Inhibitors of cholesteryl ester transfer protein - a step forward in the treatment of coronary artery disease?
    Doggrell, SA
    DRUGS OF THE FUTURE, 2005, 30 (01) : 45 - 50
  • [26] The relationship between genetic defect of cholesteryl ester transfer protein with coronary artery disease
    Chae, IH
    Han, KH
    Choe, SC
    Kim, HS
    Park, YB
    Choi, YS
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 65 - 65
  • [27] Cholesteryl ester transfer protein inhibitors as potential new therapies for coronary artery disease
    Sikorski, James A.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (06) : 753 - 772
  • [28] Chemometric modeling and pharmacophore mapping in coronary heart disease: 2-arylbenzoxazoles as cholesteryl ester transfer protein inhibitors
    Jana, Dhritiman
    Halder, Amit Kumar
    Adhikari, Nilanjan
    Maiti, Milan Kumar
    Mondal, Chanchal
    Jha, Tarun
    MEDCHEMCOMM, 2011, 2 (09) : 840 - 852
  • [29] Carriers of three polyrnorphisms of cholesteryl ester transfer protein gene are at increased risk to coronary heart disease in a Chinese population
    Zheng, KQ
    Zhang, SZ
    Zhang, L
    He, Y
    Liao, LC
    Hou, YP
    Huang, DJ
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 103 (03) : 259 - 265
  • [30] Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction
    Schaefer, Ernst J.
    Asztalos, Bela F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (11): : 25N - 31N
12345